XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2023
Class Of Stock [Line Items]  
Schedule of Stock-Based Compensation Expense Recognized

Total stock-based compensation expense was recognized in our condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

For the Three Months
Ended March 31,

 

 

 

2023

 

 

2022

 

Research and development

 

$

397

 

 

$

880

 

General and administrative

 

 

984

 

 

 

1,306

 

Total stock-based compensation

 

$

1,381

 

 

$

2,186

 

Common Stock Warrants [Member]  
Class Of Stock [Line Items]  
Schedule of Warrant Activity

As of March 31, 2023, there were 1,145,631 warrants exercisable into common stock (rounding for fractional shares and subject to beneficial ownership blockers).

 

 

 

Roll Forward of Warrant Activity

 

 

 

Registered direct
warrants, placement agent

 

 

Private placement warrants

 

 

Private placement warrants, placement agent

 

 

Warrants exchanged for common stock

 

 

Warrants exchanged for Series X1 preferred stock

 

 

Total

 

Balance as of December 31, 2022

 

 

9,581

 

 

 

319,064

 

 

 

9,177

 

 

 

509,117

 

 

 

298,692

 

 

 

1,145,631

 

Issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2023

 

 

9,581

 

 

 

319,064

 

 

 

9,177

 

 

 

509,117

 

 

 

298,692

 

 

 

1,145,631

 

Preferred Stock Warrants [Member]  
Class Of Stock [Line Items]  
Schedule of Warrant Activity

As of March 31, 2023, there were 50,207.419 warrants exercisable into Series X1 Preferred Stock, which are convertible into 2,789,301 shares of common stock (rounding for fractional shares and subject to beneficial ownership conversion blockers).

 

 

 

Roll Forward of
Series X
1
Convertible
Preferred
Warrant
Activity

 

 

 

Total

 

Balance as of December 31, 2022

 

 

50,207.419

 

Assumed and replaced

 

 

 

Exercised

 

 

 

Cancelled/Expired

 

 

 

Balance as of March 31, 2023

 

 

50,207.419